P&G's Soft Outlook: 2 Signals That Would Make Me Buy
💡 Key Takeaway
P&G's fiscal 2027 guidance came in below expectations due to $1.36B in cost headwinds, but the stock isn't a buy until volume growth returns or the price drops to ~$130.
What Happened: P&G's Guidance Disappoints
Procter & Gamble (PG) reported its fiscal fourth-quarter and full-year 2026 results last week, and the market's reaction has been muted at best. The stock trades near $144, just 5% above its 52-week low of $137.62. The headline numbers were mixed: net sales rose 2% year over year to $21.2 billion in Q4, but organic sales were flat. Core earnings per share of $1.43 declined 3% from the prior year.
For the full fiscal year, net sales grew 3% to $87.0 billion, but organic sales grew only 1%, and all of that growth came from pricing—volume and mix were unchanged. This deceleration is concerning: organic growth slowed from 1% for the year to flat in the fourth quarter.
The real shock came with the fiscal 2027 guidance. Management expects organic sales growth of just 1% to 3% and core EPS of $6.89 to $7.11, with the midpoint implying less than 2% growth. This came in slightly below analyst expectations.
The reason for the soft outlook is a $1 billion after-tax headwind from higher raw-material, energy, and transportation costs. Add in higher net interest expense ($150 million), lower non-operating income ($150 million), and unfavorable currency ($50 million), and the total drag is $0.56 per share—about 8 percentage points of EPS growth wiped out before the year begins.
CEO Shailesh Jejurikar called fiscal 2026 "a year of foundation building," but the fiscal 2027 outlook suggests the payoff is still a year or more away. The company is absorbing these costs, and investors are left waiting for a turnaround.
Why It Matters: Growth Stalled, Costs Rising
P&G's guidance is a clear signal that the company is facing significant margin pressure. The $1.36 billion in total headwinds will eat into earnings, and with organic sales growth expected at just 1-3%, the company's ability to grow profits is severely limited. This is a stark contrast to the double-digit EPS growth investors have come to expect from a blue-chip staple.
The fact that all organic growth is coming from pricing, with volumes flat, is a red flag. It suggests P&G may be reaching the limits of its pricing power. Consumers are paying more for Tide and Pampers, but they aren't buying more. This is unsustainable in the long run and could lead to market share losses if competitors undercut on price.
For investors, this means the stock's near-term upside is capped. With a P/E of about 21 times fiscal 2026 earnings, the valuation is not cheap enough to compensate for the lack of growth. The stock is trading near its 52-week low, but that low might not hold if the company fails to meet its already-low guidance.
However, there is a silver lining. Excluding the cost headwinds, P&G would be growing core EPS at about 10%. This suggests the underlying business is healthy, and the cost pressures are cyclical. If commodity prices ease, P&G could see a significant earnings boost. But for now, the market is focused on the near-term pain.
The stock's 3% dividend yield provides some downside protection, and the company's commitment to returning $15 billion to shareholders in fiscal 2027 is reassuring. But for growth-oriented investors, P&G may not be the best place to park money right now.
Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight
Wait for P&G to show volume growth or a better entry point near $130 before buying.
The stock is fairly valued at 21x earnings with low growth prospects, and the cost headwinds are real. However, the dividend is safe and the business is durable, so a patient approach is warranted. If commodity costs ease or volumes return, the stock could re-rate higher.
What This Means for Me
